Trial search - ClinicalTrials.eu

Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

↓

Matched clinical trials

Study on Elranatamab and Daratumumab for Patients with Relapsed or Refractory Multiple Myeloma After Prior Treatment

Not recruiting

1 1 1 1
Investigated drugs:
+7
Study of Nemvaleukin Alfa and Pembrolizumab for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer.

Not recruiting

1 1 1 1
Investigated diseases:
Investigated drugs:
+4
Study on the Effects of Dapagliflozin on Blood Vessel Health in Patients with Chronic Kidney Disease

Not recruiting

1 1 1
Investigated diseases:
- Chronic kidney disease
Investigated drugs:
- Dapagliflozin
Study Comparing Avelumab, Cetuximab, and Radiotherapy with Standard Treatments for Patients with Advanced Head and Neck Squamous Cell Carcinoma

Not recruiting

1 1 1 1
Investigated diseases:
- Squamous cell carcinoma of head and neck
Investigated drugs:
Study Comparing DTG/3TC and BIC/FTC/TAF for Maintaining HIV Control in Adults

Not recruiting

1 1 1 1
Investigated drugs:
Study of SY-1425 (tamibarotene) alone or with azacitidine in adult patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Not recruiting

1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
- Tamibarotene
- Azacitidine
Study Comparing BI 907828 and Doxorubicin for Patients with Advanced Dedifferentiated Liposarcoma

Not recruiting

1 1 1 1
Investigated diseases:
- Liposarcoma
Investigated drugs:
- (3S,3’S,3A’s,10A’s)-6-Chloro-3′-(3-Chloro-2-Fluorophenyl)-1′-(Cyclopropylmethyl)-6′-Methyl-2-Oxo-1,2,3′,3A’,10′,10A’-Hexahydro-1’H-Spiro[Indole-3,2′-Pyrrolo[2′,3′:4,5]Pyrrolo[1,2-B]Indazole]-7′-Carboxylic Acid
- Doxorubicin Hydrochloride
+6
Study Comparing Infliximab Alone or with Immunosuppressive Drugs for Moderate to Severe Crohn’s Disease Patients

Not recruiting

1 1 1 1
Investigated diseases:
- Inflammatory bowel disease
Investigated drugs:
- Infliximab
Study of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy

Not recruiting

1 1 1
Investigated diseases:
Investigated drugs:
- Obinutuzumab
Study on the Safety and Imaging of Risankizumab-800CW for Patients with Inflammatory Bowel Disease

Not recruiting

1 1 1
Investigated diseases:
- Inflammatory bowel disease
Investigated drugs:
- Risankizumab

Find clinical trials in your area

Matched clinical trials

We use cookies